
Loading, please wait...

Loading, please wait...

Moreover, intravenous lipid emulsion safety is a vital consideration because clinicians use it as a rescue antidote. However, potential effects on coagulation remain a concern so researchers performed a prospective crossover study. Consequently, they evaluated healthy Beagles and analyzed their viscoelastic parameters. Therefore, the study aimed to detect any induced hypocoagulability. Additionally, the team compared ILE to a control group because they needed a baseline for comparison.
Specifically, the dogs received a standard dose and then researchers measured clotting times. After that, they observed that clot formation times increased but platelet counts remained stable. Furthermore, the alpha angle decreased slightly and the clot amplitude was lower. In contrast, the prothrombin time increased after LRS administration so the changes were unique to the infusion type. Accordingly, most measurements stayed within reference intervals and thus the clinical impact was minimal. Consequently, ILE was well tolerated and it did not cause significant bleeding. Therefore, practitioners can trust the safety of this protocol because the results support its use. Finally, while statistically significant, the changes are clinically irrelevant and so ILE remains a safe rescue option.
Based on current study data, ILE may cause minor statistical changes in clot formation time, but these typically remain within normal reference ranges and do not lead to clinical bleeding.
Yes, the study used the standard antidotal protocol: a 2 mL/kg bolus followed by a 0.25 mL/kg/min infusion for 60 minutes.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or substitute for professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Study evaluating the effect of 20% intravenous lipid emulsion (ILE) on coagulation, finding that changes are statistically minor and clinically insignifican...
4 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today